Date: Mar 04, 2013 Source: Lifespan (
click here to go to the source)
Samuel C. Dudley, MD, PhD has been appointed chief of the division of cardiology at the Cardiovascular Institute (CVI) at Rhode Island and The Miriam hospitals and chief of the division of cardiology in the Department of Medicine at The Warren Alpert Medical School of Brown University. In this role, Dudley will oversee all cardiology services on the two campuses including patient care and clinical research. He is also responsible for the research and educational programs at all the Brown teaching hospitals to further strengthen the program's position as a regional and national leader in cardiac care. His appointment is effective March 1, 2013.
"Dr. Dudley is a unique combination of physician, researcher and entrepreneur," said Timothy J. Babineau, MD, president and chief executive officer of Lifespan. "We are confident that his leadership skills and hands-on approach will serve to strengthen the program and support all cardiac physicians; that his compassion and commitment to the highest quality patient care will be of great benefit to our patients; and that his commitment to cutting-edge research will solidify our cardiac program as one of the best in the country."
Dudley's research efforts into such areas as sudden cardiac death have resulted in the development of an innovative blood test designed to identify those patients most at risk. His entrepreneurial spirit has led him to receive more than 20 patents and to launch a biotech firm focused specifically on commercializing this blood test.
"We look forward to the important contributions that Dr. Dudley will make to education and research in cardiology. His clinical skills and research interests strongly complement clinicians and researchers at the Medical School, in the basic science departments and public health." said Edward J. Wing, MD, dean of medicine and biological sciences at Alpert Medical School.
Dudley comes to Rhode Island and The Miriam hospitals from the University of Illinois at Chicago where he served as chief of cardiology and co-director of the Center for Cardiovascular Research. He previously served as chief of cardiology at the Atlanta (Ga.) VA Medical Center and associate professor of medicine and physiology at Emory University in Atlanta.
Dudley earned his bachelor's degree from the University of Virginia in Charlottesville, and his medical degrees from the Medical College of Virginia, Virginia Commonwealth University. He completed his residency, postdoctoral fellowship and cardiology fellowship at the University of Chicago. He serves on several editorial boards for publications including the Frontiers in Cardiac Electrophysiology; Journal of The American College of Cardiology; Journal of Cardiovascular Pharmacology and Therapeutics; and The Open Biochemistry Journal. He is fellow of the American College of Cardiology and the American Heart Association and is a member of the Association of University Cardiologists, the American Society of Clinical Investigation, Heart Rhythm Society, Cardiac Electrophysiology Society, and the Cardiac Muscle Society, among others.
His research interests include cardiac cell replacement therapy, diastolic heart failure and sudden cardiac death. He has published more than 90 manuscripts and book chapters and is the inventor on more than 20 patents including a blood test to predict sudden death risk, a blood test for diastolic heart failure, a possible treatment for diabetes and obesity and eight novel therapeutics for diastolic heart failure and sudden death prevention. He is chief science officer of ROS Technologies, a company he founded to commercialize the blood test for sudden death risk.
The Cardiovascular Institute (CVI) at Rhode Island Hospital and The Miriam Hospital is a collaboration of cardiovascular services at the two campuses, along with cardiology programs in the community. The CVI bridges cardiac experts on both campuses, providing them with the necessary resources to deliver streamlined, high-quality, patient-centered care with the latest tools and technologies available for diagnosis and treatment.
